Skip to content
2000
Volume 12, Issue 10
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

The brain serotonin (5-HT) and dopamine (DA) systems are targets for many clinically effective antidepressants. Here, we studied the effects of acute administration of a new potential antidepressant drug, 8-(trifluoromethyl)-1,2,3,4,5 - benzopentathiepin-6-amine hydrochloride (TC-2153), on the concentration of 5-HT and DA as well as their main metabolites, 5-hydroxyindoleacetic (5-HIAA) and homovanillic acids (HVA), in the brain. TC-2153 at the doses of 10, 20 or 40 mg/kg was administered by ip injection to adult C57BL/6 mouse males. The levels of 5-HT, 5-HIAA, DA and HVA in the hypothalamus, hippocampus, striatum, midbrain were assayed an hour after treatment using high performance liquid chromatography with electrochemical detection. It was found that 20 and 40 mg/kg of TC-2153 significantly increased 5-HT, 5-HIAA, DA and HVA levels as well as the HVA/DA ratio in the hypothalamus. At the same time, the drug produced no effect on 5-HT, 5-HIAA, DA and HVA levels in the hippocampus, striatum, midbrain or substantia nigra. Therefore, the hypothalamic 5-HT and DA systems are targets for acute TC-2153 injection.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/1570180812666150522221634
2015-12-01
2025-06-26
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/1570180812666150522221634
Loading

  • Article Type:
    Research Article
Keyword(s): acute treatment; benzopentathiepine; brain; dopamine; mice; serotonin; TC-2153
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test